Today: 10 June 2026
Ford stock today: F ends 2025 at $13.12 as New Year’s holiday halts trading; Tesla deliveries in focus
1 January 2026
2 mins read

Ford stock today: F ends 2025 at $13.12 as New Year’s holiday halts trading; Tesla deliveries in focus

NEW YORK, January 1, 2026, 07:05 ET — Market closed.

  • Ford shares last closed down 0.83% at $13.12 on Dec. 31, the final U.S. session of 2025.
  • Investors are watching Tesla’s Q4 delivery report and early-January economic data for signals on EV demand and consumer spending.
  • Ford’s next scheduled company catalyst is its Feb. 10 quarterly results.

Ford Motor (F.N) shares closed down 0.83% at $13.12 on Wednesday, the last trading day before U.S. stock markets shut for New Year’s Day. The shares traded between $13.12 and $13.22, with about 26.3 million shares changing hands and a 52-week range of $8.44 to $13.99, according to Investing.com data.

Markets are dark on Thursday, leaving investors to reset positions into Friday’s first session of 2026. For automakers, the opening stretch of the year often sets the tone on two pressure points: consumer demand and pricing.

For Ford, a key near-term read-through comes from Tesla’s fourth-quarter delivery report on Friday. Deliveries — vehicles handed over to customers — are watched closely because they are one of the earliest hard datapoints on electric-vehicle demand and discounting.

Analysts expect Tesla’s deliveries to fall about 13% from a year earlier to about 432,810 vehicles, a Visible Alpha poll showed, after U.S. tax credits expired in September, Reuters reported. “The fall will be driven largely by sales in North America and Europe,” Deutsche Bank analyst Edison Yu wrote. Reuters

Ford has been pivoting spending toward trucks, hybrids and lower-cost electric models as it tries to lift margins and cut losses in its EV business. The company is scheduled to report fourth-quarter and full-year results on Feb. 10, Ford said in a December update.

General Motors (GM.N) fell 1.23% to $81.32 on Wednesday and Tesla (TSLA.O) slid 1.04% to $449.72, underscoring a soft tone for autos in the final session of 2025, MarketWatch data showed.

With no U.S. trading on Thursday, attention turns to Friday’s data and headlines that can swing risk appetite, including factory-activity surveys and interest-rate expectations. Autos tend to react quickly when yields move because most new vehicles are financed.

S&P Global is due to publish final December readings for its U.S. manufacturing purchasing managers’ index, or PMI, on Jan. 2. The PMI is a survey-based gauge of business conditions; readings above 50 indicate expansion.

Ford also faces a political spotlight later this month: the Senate Commerce Committee has set a Jan. 14 hearing on vehicle affordability and invited Ford CEO Jim Farley to testify. The witness list includes the CEOs of GM and Stellantis and a senior Tesla executive, a committee notice showed.

Before Friday’s opening bell, traders will likely use Thursday’s holiday to recalibrate around the $13 level, a psychological marker that often attracts short-term buyers and sellers. Ford ended Wednesday just above that level, about 6% below its 52-week high.

A rebound in EV sentiment after Tesla’s delivery report could help lift Ford and other legacy automakers, but investors will also be watching for signs that discounting is returning in 2026. Pricing matters because incentives typically hit margins fast.

Ford’s Feb. 10 results are the next scheduled company event after the holiday break. Traders will be looking for clues on 2026 volume and pricing, the pace of cost cuts, and cash generation in Ford Pro and Ford Blue — its commercial and traditional combustion businesses.

Stock Market Today

  • Apotex Shares Surge in Largest TSX IPO Since 2021
    June 10, 2026, 11:27 AM EDT. Shares of Canadian generic drug maker Apotex Health jumped 17% in their Toronto Stock Exchange debut, raising about C$1.3 billion in gross proceeds, the largest Canadian IPO since 2021. Apotex priced 54.17 million shares at C$24, at the top of its range, signaling strong investor demand. The offering provides rare exposure to the Canadian healthcare sector, which is underrepresented on the TSX dominated by financials and energy stocks. Owned previously by SK Capital Partners, Apotex plans to expand high-margin drugs and global markets. The successful IPO could encourage more Canadian firms to explore public markets for growth capital.

Latest articles

Dow Drops After CPI Surprise, Iran Concerns Keep Fed Outlook Uncertain

Dow Drops After CPI Surprise, Iran Concerns Keep Fed Outlook Uncertain

10 June 2026
Dow drops 0.55% to 50,592 after May CPI jumps 4.2% year-on-year, matching forecasts but fueled by a 7% surge in gasoline prices and rising energy costs, as renewed U.S.-Iran tensions and sharp losses in AI and industrial stocks add to investor caution, with Super Micro Computer plunging 14.2% on $7 billion equity plans and XPO, J.B. Hunt, Old Dominion falling up to 6.2% after Amazon expands freight service.
S&P 500 Swings After Hot CPI, AI Names Under Pressure

S&P 500 Swings After Hot CPI, AI Names Under Pressure

10 June 2026
May inflation jumped 4.2%—the fastest pace since April 2023—matching forecasts but keeping the Fed on hold, as energy prices fueled the rise; S&P 500 and Nasdaq steadied after early losses, but AI-linked stocks slid, with Super Micro Computer tumbling on a $7 billion share sale plan that risks diluting investors.
Chewy Drops After Q1 Beat With Outlook Warning

Chewy Drops After Q1 Beat With Outlook Warning

10 June 2026
Chewy slashed its 2026 net sales outlook to $13.40–$13.55 billion, below prior guidance and analyst estimates, sending shares down 50 cents to $19.90 as investors reacted to weaker-than-expected second-quarter forecasts despite a 7.7% first-quarter sales jump and improved profitability.
Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD
Previous Story

Outlook Therapeutics stock drops after FDA issues another Lytenava CRL for wet AMD

Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next
Next Story

Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next

Go toTop